Dex Surgical Overview

  • Founded
  • 2008

  • Status
  • Private

  • Employees
  • 5

  • Latest Deal Type
  • 2ndary - Private

Dex Surgical General Information


Manufacturer of surgical robotized instruments intended for easy access in narrow spaces during advanced surgery. The company's instruments offer an agile robot designed for precise, safe, reproducible, and comfortable minimally invasive surgery that helps to cut, dissect and suture a precise and safe minimal invasive surgery while decreasing discomfort and fatigue, enabling surgeons with easy wrist mobility during laparoscopy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Primary Office
  • 3 Rue des Petits Ruisseaux
  • 91370 Verrières-le-Buisson
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dex Surgical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Dex Surgical’s complete valuation and funding history, request access »

Dex Surgical Patents

Dex Surgical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2996113-B1 Manipulator for mini-invasive surgery operation Expired - Fee Related 02-Oct-2012 0000000000
FR-2996113-A1 Manipulator for mini-invasive surgery operation Granted 02-Oct-2012 0000000000 0
FR-2948596-A1 Manipulator hand held and symmetric pretension Granted 31-Jul-2009 00000000000 0
FR-2948596-B1 Manipulator hand held and symmetric pretension Active 31-Jul-2009 00000000000
US-8613740-B2 Hand-held manipulator with symmetrical grip Expired - Fee Related 31-Jul-2009 A61B17/2909 0
To view Dex Surgical’s complete patent history, request access »

Dex Surgical Executive Team (5)

Name Title Board Seat Contact Info
Remi Rosset Ph.D Co-Founder & Scientific Manager
Guillaume Noury Chief Executive Officer
You’re viewing 2 of 5 executive team members. Get the full list »

Dex Surgical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial